1026397-29-4

Upstream product

• 119085-51-7 N-[2-(3,4-Dimethoxy-phenyl)-2-hydroxy-ethyl]-3-ethanesulfonylamino-benzamide 
• 119085-52-8 Ethanesulfonic acid (3-{[2-(3,4-dimethoxy-phenyl)-2-hydroxy-ethylamino]-methyl}-phenyl)-amide 
• 119085-53-9 Ethanesulfonic acid [4-(3,4-dimethoxy-phenyl)-1,2,3,4-tetrahydro-isoquinolin-7-yl]-amide 
• 849410-09-9 ethyl 3-[(ethylsulfonyl)amino]benzoate 
• 117292-19-0 3-(ethylsulfonamido)benzoic acid 
• 15471-89-3 α-(aminomethyl)-3,4-dimethoxybenzyl alcohol hydrochloride 
• 582-33-2 3-aminobenzoic acid ethyl ester 
• 119085-54-0 Ethanesulfonic acid [2-acetyl-4-(3,4-dimethoxy-phenyl)-1,2,3,4-tetrahydro-isoquinolin-7-yl]-amide 

Relevant academic research and scientific papers

4-(3,4-dihydroxyphenyl)-1,2,3,4-tetrahydroisoquinoline derivatives. II. Their renal vasodilation activity and structure-activity relationship

A series of 4-(3,4-dihydroxyphenyl)-1,2,3,4-tetrahydroisoquinoline derivatives showed potent DA1 agonistic activities. We investigated the structure-activity relationship of the racemic compounds of this series. 4- (3,4-Dihydroxyphenyl)-7-metha